Safety and efficacy of GammaTile intracranial brachytherapy implanted during awake craniotomy

GammaTile intracranial brachytherapy (cesium-131 seeds) has demonstrated encouraging safety and local control results, and recently received Food and Drug Administration clearance for newly diagnosed and recurrent brain tumors. The authors present the first reported case of GammaTile intraoperative brachytherapy performed during an awake craniotomy.

Source: Brachytherapy - September 26, 2021 Category: Cancer & Oncology Authors: Shearwood McClelland, Ulysses G Gardner, Yi Le, Sook Kien Ng, Mitesh V Shah, Gordon A Watson Source Type: research